5.45
price down icon10.66%   -0.65
after-market Dopo l'orario di chiusura: 5.75 0.30 +5.50%
loading

Coya Therapeutics Inc Azioni (COYA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
97.89%
0.1268
6.0022 - - -
Operating Expenses
33.98%
5.6098
4.1871 3.5641 3.2543 2.9001
Benefits Costs and Expenses
5.1788
- - - -
Costs And Expenses
5.1788
- - - -
Operating Income/Loss
402.07%
-5.483
1.8152 -3.5641 -3.2543 -2.9001
Income/Loss From Continuing Operations Before Tax
353.89%
-5.0519
1.9898 -3.422 -3.0954 -2.7365
Income/Loss From Continuing Operations After Tax
499.05%
-5.0519
1.266 -3.422 -3.0954 -2.7365
Net Income/Loss
499.05%
-5.0519
1.266 -3.422 -3.0954 -2.7365
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4,878%
14.46
0.2905 9.9479 9.9479 9.7218
Diluted Average Shares
4,878%
14.46
0.2905 9.9479 9.9479 9.7218
Basic Earnings Per Share
333.33%
-0.35
0.15 -0.34 -0.31 -0.28
Diluted Earnings Per Share
333.33%
-0.35
0.15 -0.34 -0.31 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):